In the other 6 cancer types (group 2: head and neck, prostate, glioma, cervical, glioblastoma and kidney chromophobe) CDH10 expression was lost or reduced, but this was not correlated with increased EHMT2 expression. Here, CDH10 is linked to central nervous system cancer.